Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid, Malignant Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01455571
What this trial is testing

Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Hanmi Pharmaceutical Company Limited 55
Early research (Phase 1)UnknownNCT04612504
What this trial is testing

SynOV1.1 Intratumoral Injection Study

Who this might be right for
Hepatocellular Carcinoma
Beijing Syngentech Co., Ltd. 15
Early research (Phase 1)Study completedNCT04617314
What this trial is testing

RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumor
RemeGen Co., Ltd. 67
Early research (Phase 1)Looking for participantsNCT06515314
What this trial is testing

HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors

Who this might be right for
Hepatic Cell Carcinoma
Shanghai Ruiliyuan Biotechnology Co., Ltd. 12
Early research (Phase 1)Study completedNCT00104364
What this trial is testing

MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)

Who this might be right for
Cancer
Merck Sharp & Dohme LLC 30
Early research (Phase 1)Ended earlyNCT00473616
What this trial is testing

Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan

Who this might be right for
Advanced Solid TumorsCancerAdvanced Solid Malignancies
AstraZeneca 60
Testing effectiveness (Phase 2)Study completedNCT04172506
What this trial is testing

Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors

Who this might be right for
Solid TumorLung CancerHCC
Akeso 65
Early research (Phase 1)Study completedNCT00075933
What this trial is testing

ARQ 501 in Subjects With Cancer

Who this might be right for
Cancer
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 80
Early research (Phase 1)Study completedNCT03343054
What this trial is testing

Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors

Who this might be right for
NeoplasmsBreast Neoplasms
Pfizer 28
Early research (Phase 1)Study completedNCT00483366
What this trial is testing

Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Nebraska 13
Early research (Phase 1)Study completedNCT02239900
What this trial is testing

Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors

Who this might be right for
Liver CancerLung Cancer
M.D. Anderson Cancer Center 143
Testing effectiveness (Phase 2)Looking for participantsNCT06795412
What this trial is testing

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pyxis Oncology, Inc 220
Testing effectiveness (Phase 2)Study completedNCT04068519
What this trial is testing

Study Investigating Safety, Tolerability, Pharmacokinetics (PK) and Antitumor Activities of Anti-PD-1 (Programmed Death-1) Monoclonal Antibody

Who this might be right for
Advanced Solid Tumors
BeiGene 300
Early research (Phase 1)Study completedNCT00749502
What this trial is testing

MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)

Who this might be right for
Solid TumorsChronic Lymphocytic LeukemiaT-cell-prolymphocytic Leukemia
Tesaro, Inc. 113
Very early researchUnknownNCT05886075
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

Who this might be right for
Lung CancerBronchial CancerNon Small Cell Lung Cancer+9 more
Shanghai Yunying Medical Technology 24
Early research (Phase 1)UnknownNCT04623892
What this trial is testing

Evaluate the Tolerance and Pharmacokinetics of TQB2618 Injection in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50
Early research (Phase 1)Study completedNCT00002902
What this trial is testing

Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Abramson Cancer Center at Penn Medicine
Large-scale testing (Phase 3)Looking for participantsNCT06658353
What this trial is testing

Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Jiangsu vcare pharmaceutical technology co., LTD 54
Early research (Phase 1)Ended earlyNCT05098405
What this trial is testing

First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Molecular Partners AG 46
Testing effectiveness (Phase 2)Looking for participantsNCT07131202
What this trial is testing

FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Suzhou Forlong Biotechnology Co., Ltd 130
Next Page